Brian Carr

921 citations

36 papers · 707 indexed · h-index 15

Impact in

Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
Microbiology top 5%
- Antimicrobial Peptides and Activities

Papers in ⓘ

Oncology 15
- Drug Transport and Resistance Mechanisms 8
- CAR-T cell therapy research 5
Pharmacology 12
- Pharmacogenetics and Drug Metabolism 12
- Drug-Induced Hepatotoxicity and Protection 5

Co-authors: Thomas J. Goralski (1 shared paper)Dan Hanson (1 shared paper)Alan M. Krensky (1 shared paper)Xiaoyan Chu (1 shared paper)Raymond Evers (1 shared paper)Niresh Hariparsad (1 shared paper)Garold S. Yost (3 shared papers)Yulin Fang (3 shared papers)
Journals: Drug Metabolism and Disposition (6 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Bioconjugate Chemistry (2 papers)The Journal of Immunology (2 papers)Alcohol (2 papers)
Partner nations: United States New Zealand United Kingdom

In The Last Decade

Brian Carr

35 papers receiving 687 citations

Peers

Countries citing papers authored by Brian Carr

Since Specialization

Citations

This map shows the geographic impact of Brian Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Carr more than expected).

Fields of papers citing papers by Brian Carr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Carr. The network helps show where Brian Carr may publish in the future.

Co-authors

The 25 scholars most cited alongside Brian Carr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brian Carr Line = papers co-authored together Brian Carr links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins The Journal of Immunology ·Susan V. Peña, Dan Hanson, Brian Carr, Thomas J. Goralski, Alan M. Krensky	1997	228
2	Comparison of Immortalized Fa2N-4 Cells and Human Hepatocytes as in Vitro Models for Cytochrome P450 Induction Drug Metabolism and Disposition ·Niresh Hariparsad, Brian Carr, Raymond Evers, Xiaoyan Chu	2008	61
3	Characterization of the Rhesus Monkey CYP3A64 Enzyme: Species Comparisons of CYP3A Substrate Specificity and Kinetics Using Baculovirus-Expressed Recombinant Enzymes Drug Metabolism and Disposition ·Brian Carr, Ryan Norcross, Yulin Fang, Ping Lu, A. David Rodrigues, Magang Shou, Tom Rushmore, Catherine Booth-Genthe	2006	48
4	PD-1 Blockade and TLR7 Activation Lack Therapeutic Benefit in Chronic Simian Immunodeficiency Virus-Infected Macaques on Antiretroviral Therapy Antimicrobial Agents and Chemotherapy ·Elena Bekerman, Joseph Hesselgesser, Brian Carr, Mark Nagel, Magdeleine Hung, Adele Wang, Lance Stapleton, Agneta von Gegerfelt, Hanne Andersen Elyard, Jeffrey D. Lifson, Romas Geleziunas	2019	43
5	Endosomolytic Bioreducible Poly(amido amine disulfide) Polymer Conjugates for the in Vivo Systemic Delivery of siRNA Therapeutics Bioconjugate Chemistry ·Rubina Parmar, Marina Busuek, Eileen S. Walsh, Karen Leander, Bonnie J. Howell, Laura Sepp‐Lorenzino, Eric Kemp, Louis S. Crocker, Anthony Leone, Christopher J. Kochansky, Brian Carr, R. M. Garbaccio, Steven L. Colletti, Weimin Wang	2013	33
6	Characterization of the Human Lung CYP2F1 Gene and Identification of a Novel Lung-specific Binding Motif Journal of Biological Chemistry ·Brian Carr, Jie Wan, Ronald N. Hines, Garold S. Yost	2003	31
7	Selective Inhibition of Dog Hepatic CYP2B11 and CYP3A12 Journal of Pharmacology and Experimental Therapeutics ·Ping Lü, Suresh B. Singh, Brian Carr, Yulin Fang, Cathie Xiang, Thomas H. Rushmore, A. David Rodrigues, Magang Shou	2005	29
8	HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeys PLoS Pathogens ·Brian Moldt, Abishek Chandrashekar, Erica N. Borducchi, Joseph P. Nkolola, Heather Stephenson, Mark Nagel, Magdeleine Hung, Joshua Goldsmith, Craig S. Pace, Brian Carr, N.D. Thomsen, Wade Blair, Romas Geleziunas, Dan H. Barouch	2022	23
9	In Vitro and in Vivo CYP3A64 Induction and Inhibition Studies in Rhesus Monkeys: A Preclinical Approach for CYP3A-Mediated Drug Interaction Studies Drug Metabolism and Disposition ·Thomayant Prueksaritanont, Yuhsin Kuo, Cuyue Tang, Chunze Li, Yue Qiu, Bing Lu, Kristie Strong‐Basalyga, Karen Richards, Brian Carr, Jiunn H. Lin	2006	22
10	Novel Endosomolytic Poly(amido amine) Polymer Conjugates for Systemic Delivery of siRNA to Hepatocytes in Rodents and Nonhuman Primates Bioconjugate Chemistry ·Rubina Parmar, Micheal Poslusney, Marina Busuek, Jonathan Williams, R. M. Garbaccio, Karen Leander, Eileen S. Walsh, Bonnie J. Howell, Laura Sepp‐Lorenzino, Sean Riley, Mihir Patel, Eric Kemp, Andrew H. Latham, Anthony Leone, Eric D. Soli, Rob S. Burke, Brian Carr, Steven L. Colletti, Weimin Wang	2014	21
11	Adjunct antibody administration with standard treatment reduces relapse rates in a murine tuberculosis model of necrotic granulomas PLoS ONE ·Alvaro A. Ordoñez, Supriya Pokkali, Sun-Hwa Kim, Brian Carr, Mariah H. Klunk, L. Tong, Vikram Saini, Yong S. Chang, Matthew McKevitt, Victoria Smith, David Gossage, Sanjay K. Jain	2018	20
12	Drug-metabolizing enzyme induction by 2,2′-dipyridyl, 1,7-phenanthroline, 7,8-benzoquinoline and oltipraz in mouse Xenobiotica ·Brian Carr, MICHAEL R. FRANKLIN	1998	16
13	Characterization of Pulmonary CYP4B2, Specific Catalyst of Methyl Oxidation of 3-Methylindole Molecular Pharmacology ·Brian Carr, Swayampakula Ramakanth, Ghazi A. Dannan, Garold S. Yost	2003	15
14	SP1 AND SP3 REGULATE BASAL TRANSCRIPTION OF THE HUMAN CYP2F1 GENE Drug Metabolism and Disposition ·Jie Wan, Brian Carr, N. Shane Cutler, Diane L. Lanza, Ronald N. Hines, Garold S. Yost	2005	15
15	Diclofenac hydroxylation in monkeys: Efficiency, regioselectivity, and response to inhibitors Biochemical Pharmacology ·Cuyue Tang, Yulin Fang, Catherine Booth-Genthe, Yuhsin Kuo, Scott D. Kuduk, Tom Rushmore, Brian Carr	2006	14
16	An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agents International Journal of Pharmaceutics ·Stephanie E. Barrett, Marc Abrams, Rob S. Burke, Brian Carr, Louis S. Crocker, R. M. Garbaccio, Bonnie J. Howell, Eric Kemp, Robert A. Kowtoniuk, Andrew H. Latham, Karen Leander, Anthony Leone, Mihir Patel, Sergei Pechenov, Nicole T. Pudvah, Sean Riley, Laura Sepp‐Lorenzino, Eileen S. Walsh, Jonathan Williams, Steven L. Colletti	2014	13
17	Characterization and plant expression of a glyphosate‐tolerant enolpyruvylshikimate phosphate synthase Pest Management Science ·Brian J Vande Berg, Philip E. Hammer, Betty L Chun, Laura Cooper Schouten, Brian Carr, Rong Guo, Cheryl L. Peters, T. K. Hinson, Vadim Beilinson, Amy Shekita, Rebekah Deter, Zhixian Chen, Vladimir Samoylov, Charles T. Bryant, Maria Stauffer, Timothy Eberle, D. J. Moellenbeck, Nadine B. Carozzi, Mike G Koziel, Nicholas B. Duck	2008	11
18	MK-329 blocks the inhibition of alcohol intake by CCK-8 Peptides ·Brian Carr, John D. Ballou, Julie Snell, Paul J. Kulkosky	1993	10
19	Induction of drug metabolizing enzymes by 1,7‐phenanthroline and oltipraz in mice is unrelated to Ah‐responsiveness Journal of Biochemical and Molecular Toxicology ·Brian Carr, Michael R. Franklin	1999	8
20	Conditioned Taste Aversions Induced by Alcohol and Lithium in Rats Selectively Bred for Ethanol Neurosensitivity Alcoholism Clinical and Experimental Research ·Paul J. Kulkosky, Brian Carr, Ryan Flores, A. F. LaHeist, Laura Hopkins	1995	7

About Brian Carr

Brian Carr is a scholar working on Oncology, Pharmacology, Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 36 papers that have together received 707 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (8 papers), Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (5 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Immune Cell Function and Interaction (4 papers) and Advanced biosensing and bioanalysis techniques (3 papers). The work is most often cited by research in Pharmacology (180 citations), Microbiology (99 citations), Virology (65 citations), Immunology (204 citations) and Infectious Diseases (87 citations). Brian Carr has collaborated with scholars based in United States, New Zealand and United Kingdom. Frequent co-authors include Thomas J. Goralski, Dan Hanson, Alan M. Krensky, Xiaoyan Chu, Raymond Evers, Niresh Hariparsad, Garold S. Yost, Yulin Fang, Magang Shou and Jie Wan. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, Bioconjugate Chemistry, The Journal of Immunology and Alcohol.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact